Sevva, C.; Divanis, D.; Tsinari, A.; Grammenos, P.; Laskou, S.; Mantalobas, S.; Paschou, E.; Magra, V.; Kopsidas, P.; Kesisoglou, I.;
et al. Pharmaceutical Management of Secondary Hyperparathyroidism and the Role of Surgery: A 5-Year Retrospective Study. Medicina 2024, 60, 812.
https://doi.org/10.3390/medicina60050812
AMA Style
Sevva C, Divanis D, Tsinari A, Grammenos P, Laskou S, Mantalobas S, Paschou E, Magra V, Kopsidas P, Kesisoglou I,
et al. Pharmaceutical Management of Secondary Hyperparathyroidism and the Role of Surgery: A 5-Year Retrospective Study. Medicina. 2024; 60(5):812.
https://doi.org/10.3390/medicina60050812
Chicago/Turabian Style
Sevva, Christina, Dimitrios Divanis, Ariti Tsinari, Petros Grammenos, Styliani Laskou, Stylianos Mantalobas, Eleni Paschou, Vasiliki Magra, Periklis Kopsidas, Isaak Kesisoglou,
and et al. 2024. "Pharmaceutical Management of Secondary Hyperparathyroidism and the Role of Surgery: A 5-Year Retrospective Study" Medicina 60, no. 5: 812.
https://doi.org/10.3390/medicina60050812
APA Style
Sevva, C., Divanis, D., Tsinari, A., Grammenos, P., Laskou, S., Mantalobas, S., Paschou, E., Magra, V., Kopsidas, P., Kesisoglou, I., Liakopoulos, V., & Sapalidis, K.
(2024). Pharmaceutical Management of Secondary Hyperparathyroidism and the Role of Surgery: A 5-Year Retrospective Study. Medicina, 60(5), 812.
https://doi.org/10.3390/medicina60050812
